10770sek
1,4 %
Date:2026-02-20Time:17:09:25Latest report:Q4-2025List:Mid CapTicker:BIOG B
Market Cap:10 875 msekEnterprise Value:10 074 msekNet Sales:1 538 msekEarnings:332,8 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:107,70
MA50:106,40
MA200:103,49
Price/MA200:3,9 %
RSI (14):52,8
Price/MA50:1,0 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.